Insider Trading History of Biomarin Pharmaceutical Inc

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) by Biomarin Pharmaceutical Inc since 2009. The trader's CIK number is 1048477. At the time of the last reporting, Biomarin Pharmaceutical Inc was the 10% Owner of Catalyst Pharmaceuticals, Inc.. (stock ticker symbol CPRX). Also see all insider trading activities at Catalyst Pharmaceuticals, Inc..

Note that in the past BIOMARIN PHARMACEUTICAL INC also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at La Jolla Pharmaceutical Co (LJPC) by Biomarin Pharmaceutical Inc

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2009 LJPC 0 $0 5,706,733 $1,202,639 0 $0

Yearly summary of insider trading at Catalyst Pharmaceuticals, Inc. (CPRX) by Biomarin Pharmaceutical Inc

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2012 CPRX 5,000,000 $3,750,000 0 $0 0 $0


Insider trading activities at 2 companies by Biomarin Pharmaceutical Inc:

1. La Jolla Pharmaceutical Co (LJPC)

2. Catalyst Pharmaceuticals, Inc. (CPRX)

Table 1. Insider trading of La Jolla Pharmaceutical Co (LJPC) by Biomarin Pharmaceutical Inc

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2009-06-19 LJPC Sale 2,546,958 .21 524,673
2009-06-18 LJPC Sale 2,198,825 .21 461,753
2009-06-17 LJPC Sale 960,950 .23 216,213

Table 2. Insider trading of Catalyst Pharmaceuticals, Inc. (CPRX) by Biomarin Pharmaceutical Inc

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2012-12-08 CPRX Buy 5,000,000 .75 3,750,000

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Biomarin Pharmaceutical Inc (10% Owner of Catalyst Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.